For research use only. Not for therapeutic Use.
Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) is a monoclonal antibody targeting Integrin a5b1 (ITGA5 & ITGB1). It can be used in treatment of solid tumors, renal cell carcinoma, melanoma, pancreatic cancer, lung cancer, and ovarian cancer. MW :145.52 KD.
| Catalog Number | I047518 |
| Purity | ≥95% |
| Reference | [1] Ng CM, et al. Cancer Chemother Pharmacol. 2010 Jan;65(2):207-17 |
